Adrian Cabrera
Director/Board Member at Kiniciti
Profile
Mr. Cabrera is a Principal, having joined WCAS in 2016.
Prior to joining WCAS, Mr. Cabrera was with Citigroup’s Investment Banking team.
Adrian Cabrera active positions
| Companies | Position | Start |
|---|---|---|
Welsh, Carson, Anderson & Stowe
 Welsh, Carson, Anderson & Stowe Investment ManagersFinance Welsh, Carson, Anderson & Stowe (WCAS) is a private equity firm founded in 1979 by Patrick Welsh, Russ Carson and Bruce Anderson. The firm is headquartered in New York. | Private Equity Investor | 01/07/2019 |
Kiniciti
 Kiniciti Information Technology ServicesTechnology Services Kiniciti is a platform company that invests in and partners with companies to strengthen the cell and gene therapy ecosystem. The company, which is based in New York, NY, was founded by Geoffrey Michael Glass, who has been the CEO since incorporation. Kiniciti is backed by private equity firm Welsh, Carson, Anderson & Stowe (WCAS) and Biospring Partners. The company offers a highly tailored, collaborative, and flexible investment and strategic support model to ensure the promise of cell and gene therapeutics is delivered quickly and safely to patients worldwide. The leadership team includes professionals experienced in investing in and building successful companies across the life sciences sector. | Director/Board Member | 01/01/2021 |
Training of Adrian Cabrera
| Florida International University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Welsh, Carson, Anderson & Stowe
Welsh, Carson, Anderson & Stowe Investment ManagersFinance Welsh, Carson, Anderson & Stowe (WCAS) is a private equity firm founded in 1979 by Patrick Welsh, Russ Carson and Bruce Anderson. The firm is headquartered in New York. | Finance |
Kiniciti
Kiniciti Information Technology ServicesTechnology Services Kiniciti is a platform company that invests in and partners with companies to strengthen the cell and gene therapy ecosystem. The company, which is based in New York, NY, was founded by Geoffrey Michael Glass, who has been the CEO since incorporation. Kiniciti is backed by private equity firm Welsh, Carson, Anderson & Stowe (WCAS) and Biospring Partners. The company offers a highly tailored, collaborative, and flexible investment and strategic support model to ensure the promise of cell and gene therapeutics is delivered quickly and safely to patients worldwide. The leadership team includes professionals experienced in investing in and building successful companies across the life sciences sector. | Technology Services |
- Stock Market
- Insiders
- Adrian Cabrera
